Mixed
Ethnic disparities in Type 2 Diabetes are influenced by genetic variations regulating lipid and amino acid metabolism, leading to distinct metabolic signatures and drug responses across populations.
Your ethnic background influences how your body metabolizes nutrients and responds to medications for Type 2 Diabetes. This is due to genetic variations affecting lipid and amino acid metabolism. Discuss your specific metabolic profile with your healthcare provider to tailor dietary and therapeutic strategies, as personalized approaches are more likely to succeed than generic ones.
Genetic heterogeneity, dietary patterns, nutrient metabolism and gut microbiome composition attribute to ethnic disparities in both manifestation and progression of T2D. These factors differentially regulate the rate of metabolism and metabolic health.
Why this rating
Supported by GWAS, metabolomics, and clinical studies cited.
Source
Ethnic disparities attributed to the manifestation in and response to type 2 diabetes: insights from metabolomics
Sampara Vasishta et al. · Metabolomics · 2022
DOI 10.1007/s11306-022-01905-8
More from this paper
- South Asian ethnicity is associated with a significantly higher risk of developing Type 2 Diabetes (T2D) and insulin resistance compared to White populations, driven by distinct metabolic signatures including elevated branched-chain amino acids (BCAAs) and altered lipid metabolism.Good
- Elevated levels of Branched-Chain Amino Acids (BCAAs) such as leucine, isoleucine, and valine are predictive markers for Type 2 Diabetes risk across multiple ethnic groups, with specific associations to insulin resistance.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →